Literature DB >> 28674233

Prevalence and spectrum of thalassaemia in Changsha, Hunan province, China: discussion of an innovative screening strategy.

Jun He1, Houlin Zeng, Lin Zhu, Hanmei Li, Liangcheng Shi, Lanping Hu.   

Abstract

Hunan province located in the south of China has a high incidence of haemoglobinopathies. In the present study, we surveyed the accurate population frequency data of the local population in Changsha city of Hunan province in China. The data includes the carrying rate, gene mutation types and their distribution features for thalassaemia. In total, 7500 consecutive samples from five geographical areas of Changsha were analysed for both haematological and molecular parameters. Therewas a high prevalence of carriers of α-thalassaemia (2.57%), β-thalassaemia (1.9%) and both α-thalassaemia and β-thalassaemia (0.08%). Overall, 4.54% of the population in this area represented heterozygous carriers of α-thalassaemia and β-thalassaemia. The mutation spectrum of α-thalassaemia and β-thalassaemia and its haematological characterization were fully described for this area. The present study is the first to report the prevalence of thalassaemia in Hunan province population. Both α-thalassaemia and β-thalassaemia carriers are widely distributed in Changsha. The knowledge gained from the present study will allow for an estimation of the projected number of pregnant women at risk for thalassaemia, and the design of a screening strategy for the control of thalassaemia in Changsha.

Entities:  

Mesh:

Year:  2017        PMID: 28674233     DOI: 10.1007/s12041-017-0779-6

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  15 in total

1.  Alpha0 thalassaemia as a result of a novel 11.1 kb deletion eliminating both of the duplicated alpha globin genes.

Authors:  S-Q Jia; J Li; Q-H Mo; C Liao; L-Y Li; X-M Xu
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

2.  The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening.

Authors:  X M Xu; Y Q Zhou; G X Luo; C Liao; M Zhou; P Y Chen; J P Lu; S Q Jia; G F Xiao; X Shen; J Li; H P Chen; Y Y Xia; Y X Wen; Q H Mo; W D Li; Y Y Li; L W Zhuo; Z Q Wang; Y J Chen; C H Qin; M Zhong
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

3.  Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China.

Authors:  F Xiong; M Sun; X Zhang; R Cai; Y Zhou; J Lou; L Zeng; Q Sun; Q Xiao; X Shang; X Wei; T Zhang; P Chen; X Xu
Journal:  Clin Genet       Date:  2010-04-19       Impact factor: 4.438

4.  Genetic and clinical features of hemoglobin H disease in Chinese patients.

Authors:  F E Chen; C Ooi; S Y Ha; B M Cheung; D Todd; R Liang; T K Chan; V Chan
Journal:  N Engl J Med       Date:  2000-08-24       Impact factor: 91.245

5.  Treatment and complications of thalassemia major in Guangxi, Southern China.

Authors:  Xiao-Lin Yin; Zhi-Kui Wu; Yuan-Yuan He; Tian-Hong Zhou; Ya-Li Zhou; Xin Hua Zhang
Journal:  Pediatr Blood Cancer       Date:  2011-03-10       Impact factor: 3.167

Review 6.  [Beta-thalassemias: molecular, epidemiological, diagnostical and clinical aspects].

Authors:  Philippe Joly; Corinne Pondarre; Catherine Badens
Journal:  Ann Biol Clin (Paris)       Date:  2014 Nov-Dec       Impact factor: 0.459

7.  Characterization of Deletions of the HBA and HBB Loci by Array Comparative Genomic Hybridization.

Authors:  Daniel E Sabath; Michael A Bender; Vijay G Sankaran; Esther Vamos; Alex Kentsis; Hye-Son Yi; Harvey A Greisman
Journal:  J Mol Diagn       Date:  2015-11-21       Impact factor: 5.568

8.  alpha-Thalassemia caused by an unstable alpha-globin mutant.

Authors:  S A Liebhaber; Y W Kan
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

9.  Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos.

Authors:  H Van de Velde; I Georgiou; M De Rycke; R Schots; K Sermon; W Lissens; P Devroey; A Van Steirteghem; I Liebaers
Journal:  Hum Reprod       Date:  2004-01-29       Impact factor: 6.918

10.  Spectrum of β-thalassemia mutations in Guizhou Province, PR China, including first observation of codon 121 (GAA>TAA) in Chinese population.

Authors:  Sheng-Wen Huang; Xing-Mei Liu; Gui-Fang Li; Li Su; Xian Wu; Ru-Lei Wang
Journal:  Clin Biochem       Date:  2013-09-27       Impact factor: 3.281

View more
  5 in total

1.  Next-generation sequencing improves molecular epidemiological characterization of thalassemia in Chenzhou Region, P.R. China.

Authors:  Haoqing Zhang; Caiyun Li; Jianbiao Li; Shuai Hou; Danjing Chen; Haiying Yan; Shiping Chen; Saijun Liu; Zhenzhen Yin; Xiaoqin Yang; Jufang Tan; Xiaoyan Huang; Liming Zhang; Junbin Fang; Caifen Zhang; Wei Li; Jian Guo; Dongzhu Lei
Journal:  J Clin Lab Anal       Date:  2019-02-27       Impact factor: 2.352

2.  Gene Mutation Spectrum of Thalassemia Among Children in Yunnan Province.

Authors:  Ti-Long Huang; Tian-Yao Zhang; Chun-Yan Song; Yun-Bi Lin; Bao-Hua Sang; Qing-Ling Lei; Yu Lv; Chun-Hui Yang; Na Li; Xin Tian; Yue-Huang Yang; Xian-Wen Zhang
Journal:  Front Pediatr       Date:  2020-04-15       Impact factor: 3.418

3.  Molecular Spectrum, Ethnic and Geographical Distribution of Thalassemia in the Southern Area of Hainan, China.

Authors:  Ying Yu; Chunjiao Lu; Ying Gao; Cuiyun Li; Dongxue Li; Jie Wang; Hui Wei; Zhaohui Lu; Guoling You
Journal:  Front Pediatr       Date:  2022-06-10       Impact factor: 3.569

4.  Molecular prevalence of HBB-associated hemoglobinopathy among reproductive-age adults and the prenatal diagnosis in Jiangxi Province, southern central China.

Authors:  Haiyan Luo; Ting Huang; Qing Lu; Liuyang Zhang; Yonghua Xu; Yan Yang; Zhen Guo; Huizhen Yuan; Yinqin Shen; Shuhui Huang; Bicheng Yang; Yongyi Zou; Yanqiu Liu
Journal:  Front Genet       Date:  2022-09-28       Impact factor: 4.772

5.  Alpha and beta-Thalassemia mutations in Hubei area of China.

Authors:  Yaowu Zhu; Na Shen; Xiong Wang; Juan Xiao; Yanjun Lu
Journal:  BMC Med Genet       Date:  2020-01-06       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.